CYTOKINE GROWTH F R 润色咨询

CYTOKINE & GROWTH FACTOR REVIEWS

出版年份:1996 年文章数:647 投稿命中率: 开通期刊会员,数据随心看

出版周期:Bimonthly 自引率:1.0% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=853738, encodeId=cf63853e387a, content=刚刚发表一篇。去年12月投的稿,今年3月左右被拒,但编辑很nice,提了几个意见,说若是补充了相应内容后,可以再重新投稿。我们6月18号修改后重新投稿,在cover letter中把上次编辑的意见及态度都做了说明,3天后直接接收。7月3号pubmed上线,9月初文章分配了页码。<br> 第一次审稿速度是不快,但编辑说是由于圣诞节和新年假期的缘故。第二次投稿接收速度很快。一定要按编辑的意见仔细修改,需要提供漂亮的示意图。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8f65414084, createdName=ms9553147553981420, createdTime=Fri Sep 13 13:33:08 CST 2019, time=2019-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087333, encodeId=0112108e33377, content=关键词和题目的关系?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087334, encodeId=d027108e3340c, content=关键词能否从题目中提炼?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=484066, encodeId=cfaa4840663a, content=2010 8.239, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=475, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sun Aug 21 13:17:00 CST 2011, time=2011-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=474621, encodeId=492d4e4621b0, content=审稿速度:3.0 | 投稿命中率:20.0<br>经验分享:我来提供了。现在到处查不到了,我手头备了一份,贡献给大家。这个杂志是江河日下了,毕竟细胞因子研究越来越不新鲜了,而且许多研究都归到免疫等方面了。估计明年分数还得降一些吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=515, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=cellculture, createdTime=Mon Mar 28 18:08:00 CST 2011, time=2011-03-28, status=1, ipAttribution=)]
    2019-09-13 ms9553147553981420

    刚刚发表一篇。去年12月投的稿,今年3月左右被拒,但编辑很nice,提了几个意见,说若是补充了相应内容后,可以再重新投稿。我们6月18号修改后重新投稿,在cover letter中把上次编辑的意见及态度都做了说明,3天后直接接收。7月3号pubmed上线,9月初文章分配了页码。
    第一次审稿速度是不快,但编辑说是由于圣诞节和新年假期的缘故。第二次投稿接收速度很快。一定要按编辑的意见仔细修改,需要提供漂亮的示意图。

    7

    展开7条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=853738, encodeId=cf63853e387a, content=刚刚发表一篇。去年12月投的稿,今年3月左右被拒,但编辑很nice,提了几个意见,说若是补充了相应内容后,可以再重新投稿。我们6月18号修改后重新投稿,在cover letter中把上次编辑的意见及态度都做了说明,3天后直接接收。7月3号pubmed上线,9月初文章分配了页码。<br> 第一次审稿速度是不快,但编辑说是由于圣诞节和新年假期的缘故。第二次投稿接收速度很快。一定要按编辑的意见仔细修改,需要提供漂亮的示意图。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8f65414084, createdName=ms9553147553981420, createdTime=Fri Sep 13 13:33:08 CST 2019, time=2019-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087333, encodeId=0112108e33377, content=关键词和题目的关系?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087334, encodeId=d027108e3340c, content=关键词能否从题目中提炼?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=484066, encodeId=cfaa4840663a, content=2010 8.239, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=475, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sun Aug 21 13:17:00 CST 2011, time=2011-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=474621, encodeId=492d4e4621b0, content=审稿速度:3.0 | 投稿命中率:20.0<br>经验分享:我来提供了。现在到处查不到了,我手头备了一份,贡献给大家。这个杂志是江河日下了,毕竟细胞因子研究越来越不新鲜了,而且许多研究都归到免疫等方面了。估计明年分数还得降一些吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=515, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=cellculture, createdTime=Mon Mar 28 18:08:00 CST 2011, time=2011-03-28, status=1, ipAttribution=)]
    2021-12-28 Mia

    关键词和题目的关系?

    1

    展开1条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=853738, encodeId=cf63853e387a, content=刚刚发表一篇。去年12月投的稿,今年3月左右被拒,但编辑很nice,提了几个意见,说若是补充了相应内容后,可以再重新投稿。我们6月18号修改后重新投稿,在cover letter中把上次编辑的意见及态度都做了说明,3天后直接接收。7月3号pubmed上线,9月初文章分配了页码。<br> 第一次审稿速度是不快,但编辑说是由于圣诞节和新年假期的缘故。第二次投稿接收速度很快。一定要按编辑的意见仔细修改,需要提供漂亮的示意图。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8f65414084, createdName=ms9553147553981420, createdTime=Fri Sep 13 13:33:08 CST 2019, time=2019-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087333, encodeId=0112108e33377, content=关键词和题目的关系?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087334, encodeId=d027108e3340c, content=关键词能否从题目中提炼?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=484066, encodeId=cfaa4840663a, content=2010 8.239, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=475, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sun Aug 21 13:17:00 CST 2011, time=2011-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=474621, encodeId=492d4e4621b0, content=审稿速度:3.0 | 投稿命中率:20.0<br>经验分享:我来提供了。现在到处查不到了,我手头备了一份,贡献给大家。这个杂志是江河日下了,毕竟细胞因子研究越来越不新鲜了,而且许多研究都归到免疫等方面了。估计明年分数还得降一些吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=515, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=cellculture, createdTime=Mon Mar 28 18:08:00 CST 2011, time=2011-03-28, status=1, ipAttribution=)]
    2021-12-28 Gym璨烨

    关键词能否从题目中提炼?

    1

    展开1条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=853738, encodeId=cf63853e387a, content=刚刚发表一篇。去年12月投的稿,今年3月左右被拒,但编辑很nice,提了几个意见,说若是补充了相应内容后,可以再重新投稿。我们6月18号修改后重新投稿,在cover letter中把上次编辑的意见及态度都做了说明,3天后直接接收。7月3号pubmed上线,9月初文章分配了页码。<br> 第一次审稿速度是不快,但编辑说是由于圣诞节和新年假期的缘故。第二次投稿接收速度很快。一定要按编辑的意见仔细修改,需要提供漂亮的示意图。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8f65414084, createdName=ms9553147553981420, createdTime=Fri Sep 13 13:33:08 CST 2019, time=2019-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087333, encodeId=0112108e33377, content=关键词和题目的关系?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087334, encodeId=d027108e3340c, content=关键词能否从题目中提炼?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=484066, encodeId=cfaa4840663a, content=2010 8.239, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=475, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sun Aug 21 13:17:00 CST 2011, time=2011-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=474621, encodeId=492d4e4621b0, content=审稿速度:3.0 | 投稿命中率:20.0<br>经验分享:我来提供了。现在到处查不到了,我手头备了一份,贡献给大家。这个杂志是江河日下了,毕竟细胞因子研究越来越不新鲜了,而且许多研究都归到免疫等方面了。估计明年分数还得降一些吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=515, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=cellculture, createdTime=Mon Mar 28 18:08:00 CST 2011, time=2011-03-28, status=1, ipAttribution=)]
    2011-08-21 匿名用户

    2010 8.239

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=853738, encodeId=cf63853e387a, content=刚刚发表一篇。去年12月投的稿,今年3月左右被拒,但编辑很nice,提了几个意见,说若是补充了相应内容后,可以再重新投稿。我们6月18号修改后重新投稿,在cover letter中把上次编辑的意见及态度都做了说明,3天后直接接收。7月3号pubmed上线,9月初文章分配了页码。<br> 第一次审稿速度是不快,但编辑说是由于圣诞节和新年假期的缘故。第二次投稿接收速度很快。一定要按编辑的意见仔细修改,需要提供漂亮的示意图。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8f65414084, createdName=ms9553147553981420, createdTime=Fri Sep 13 13:33:08 CST 2019, time=2019-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087333, encodeId=0112108e33377, content=关键词和题目的关系?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087334, encodeId=d027108e3340c, content=关键词能否从题目中提炼?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=484066, encodeId=cfaa4840663a, content=2010 8.239, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=475, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sun Aug 21 13:17:00 CST 2011, time=2011-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=474621, encodeId=492d4e4621b0, content=审稿速度:3.0 | 投稿命中率:20.0<br>经验分享:我来提供了。现在到处查不到了,我手头备了一份,贡献给大家。这个杂志是江河日下了,毕竟细胞因子研究越来越不新鲜了,而且许多研究都归到免疫等方面了。估计明年分数还得降一些吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=515, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=cellculture, createdTime=Mon Mar 28 18:08:00 CST 2011, time=2011-03-28, status=1, ipAttribution=)]
    2011-03-28 cellculture

    审稿速度:3.0 | 投稿命中率:20.0
    经验分享:我来提供了。现在到处查不到了,我手头备了一份,贡献给大家。这个杂志是江河日下了,毕竟细胞因子研究越来越不新鲜了,而且许多研究都归到免疫等方面了。估计明年分数还得降一些吧。

    0

共14条页码: 1/2页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分